Vivos Therapeutics, Inc. has secured FDA clearance for its flagship oral medical device, designed to treat moderate to severe obstructive sleep apnea (OSA) and snoring in children. This breakthrough paves the way for Vivos to expand its reach in the pediatric market and offer a non-invasive, effective alternative to traditional treatments.